Anti-CPM antibody [EPR8052] - BSA and Azide free
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(0 Publication)
Rabbit Recombinant Monoclonal CPM antibody. Carrier free. Suitable for IHC-P, WB and reacts with Human samples.
View Alternative Names
Carboxypeptidase M, CPM
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CPM antibody [EPR8052] - BSA and Azide free (AB248972)
This data was developed using ab150405, the same antibody clone in a different buffer formulation.
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human endometrium tissue labelling CPM with purified ab150405 at 1/500. Heat mediated antigen retrieval was performed using Tris/EDTA buffer pH 9. ab97051, a HRP-conjugated goat anti-rabbit IgG (H+L) was used as the secondary antibody (1/500). Negative control using PBS instead of primary antibody. Counterstained with hematoxylin.
- WB
Lab
Western blot - Anti-CPM antibody [EPR8052] - BSA and Azide free (AB248972)
This data was developed using ab150405, the same antibody clone in a different buffer formulation.
Blocking and dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-CPM antibody [EPR8052] (<a href='/en-us/products/primary-antibodies/cpm-antibody-epr8052-ab150405'>ab150405</a>) at 1/2500 dilution
All lanes:
Human placenta tissue lysate at 10 µg
Secondary
All lanes:
HRP-conjugated goat anti-rabbit IgG, specific to the non-reduced form of IgG at 1/1000 dilution
Predicted band size: 51 kDa
Observed band size: 62 kDa
false
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CPM antibody [EPR8052] - BSA and Azide free (AB248972)
This data was developed using ab150405, the same antibody clone in a different buffer formulation.
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human uterus tissue labelling CPM with unpurified ab150405 at a dilution of 1/50.
Perform heat mediated antigen retrieval before commencing with IHC staining protocol.
- WB
Unknown
Western blot - Anti-CPM antibody [EPR8052] - BSA and Azide free (AB248972)
This data was developed using ab150405, the same antibody clone in a different buffer formulation.
All lanes:
Western blot - Anti-CPM antibody [EPR8052] (<a href='/en-us/products/primary-antibodies/cpm-antibody-epr8052-ab150405'>ab150405</a>) at 1/1000 dilution
Lane 1:
293T (Human embryonic kidney epithelial cell) cell lysate at 10 µg
Lane 2:
Human fetal kidney tissue lysate at 10 µg
Lane 3:
Human fetal liver tissue lysate at 10 µg
Lane 4:
Human placenta lysate at 10 µg
Secondary
All lanes:
HRP-conjugated goat anti-rabbit IgG at 1/2000 dilution
Predicted band size: 51 kDa
Observed band size: 62 kDa
false
- WB
Lab
Western blot - Anti-CPM antibody [EPR8052] - BSA and Azide free (AB248972)
This data was developed using ab150405, the same antibody clone in a different buffer formulation.
Blocking and dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-CPM antibody [EPR8052] (<a href='/en-us/products/primary-antibodies/cpm-antibody-epr8052-ab150405'>ab150405</a>) at 1/5000 dilution
Lane 1:
Human fetal liver tissue lysate at 10 µg
Lane 2:
Human fetal kidney tissue lysate at 10 µg
Secondary
All lanes:
HRP-conjugated goat anti-rabbit IgG, specific to the non-reduced form of IgG at 1/1000 dilution
Predicted band size: 51 kDa
Observed band size: 62 kDa
false
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CPM antibody [EPR8052] - BSA and Azide free (AB248972)
This data was developed using ab150405, the same antibody clone in a different buffer formulation.
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human hepatocellular carcinoma tissue labelling CPM with unpurified ab150405 at a dilution of 1/50.
Perform heat mediated antigen retrieval before commencing with IHC staining protocol.
Related conjugates and formulations (8)
-
Anti-CPM antibody [EPR8052]
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-CPM antibody [EPR8052]
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-CPM antibody [EPR8052]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-CPM antibody [EPR8052]
-
660 APC
APC Anti-CPM antibody [EPR8052]
-
578 PE
PE Anti-CPM antibody [EPR8052]
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-CPM antibody [EPR8052]
-
775 Alexa Fluor® 750
Alexa Fluor® 750 Anti-CPM antibody [EPR8052]
Reactivity data
Product details
ab248972 is the carrier-free version of ab150405.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
CPM is involved in peptide processing and degradation contributing to the regulation of hormonal and neurotransmitter peptides. As part of a larger proteolytic system CPM modifies the activity and half-life of bioactive peptides by removing terminal residues. Its activity influences the regulation of peptide signaling pathways. In such roles it resounds in processes like local inflammatory response and modulation of cell surface receptors. CPM’s enzymatic activity ensures the proper function of the physiological regulatory mechanisms where peptidase activity is required.
Pathways
CPM is instrumental in the kallikrein-kinin and complement pathways. In the kallikrein-kinin system CPM regulates kinin levels influencing blood pressure and inflammation. It also relates to the complement system interacting with components that participate in immune responses. CPM’s function closely links to other carboxypeptidases in these pathways enhancing its role in regulating peptide effects or degradation. Its enzymatic interactions can influence the outcomes of these pathways ensuring an adequate biological response.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com